You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Details for New Drug Application (NDA): 018938

✉ Email this page to a colleague

NDA 018938 describes DDAVP, which is a drug marketed by Nordic Pharma and Ferring Pharms Inc and is included in three NDAs. It is available from three suppliers. Additional details are available on the DDAVP profile page.

The generic ingredient in DDAVP is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Summary for 018938

Tradename:	DDAVP
Applicant:	Nordic Pharma
Ingredient:	desmopressin acetate
Patents:	0

Pharmacology for NDA: 018938

Physiological Effect	Increased Coagulation Factor VIII Activity Increased Coagulation Factor VIII Concentration

Suppliers and Packaging for NDA: 018938

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938	NDA	Ferring Pharmaceuticals Inc.	55566-2200	55566-2200-0	10 AMPULE in 1 CARTON (55566-2200-0) / 1 mL in 1 AMPULE
DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938	NDA	Ferring Pharmaceuticals Inc.	55566-2300	55566-2300-0	1 VIAL, MULTI-DOSE in 1 CARTON (55566-2300-0) / 10 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	0.004MG/ML
Approval Date:	Mar 30, 1984	TE:	AP	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	0.015MG/ML
Approval Date:	Apr 25, 1995	TE:		RLD:	No

Expired US Patents for NDA 018938

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Nordic Pharma	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-001	Mar 30, 1984	3,497,491	⤷ Get Started Free
Nordic Pharma	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-002	Apr 25, 1995	5,500,413	⤷ Get Started Free
Nordic Pharma	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-002	Apr 25, 1995	5,763,407	⤷ Get Started Free
Nordic Pharma	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-001	Mar 30, 1984	5,763,407	⤷ Get Started Free
Nordic Pharma	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-001	Mar 30, 1984	5,500,413	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.